weight loss clinic semaglutide Ozempic Northern Virginia Medical Weight

In the U.S., about 75% of adults are overweight or obese. Children arent spared

Injection-site reactions and worsening of pre-existing diabetic retinopathy are also relevant clinical concerns

Glucagon-like-peptide-1 (GLP-1) agonists are an emerging class of medications used to manage type 2 diabetes mellitus (T2DM) and weight loss, with demonstrated efficacy in reducing hemoglobin A1c levels, body mass index, and adverse cardiovascular events

Average duration of GLP-1 based therapies was 20.5 weeks

GLP-1 attacks both root causes at once

Overweight or obesity is disproportionately prevalent in PsA compared with the general population, with estimates ranging from 72% to 82%, Joseph F